Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group
Fell, D.B., Azziz-Baumgartner, E., Baker, M.G., Batra, M., Beauté, J., Beutels, P., Bhat, N., Bhutta, Z.A., Cohen, C., De Mucio, B., Gessner, B.D., Gravett, M.G., Katz, M.A., Knight, M., Lee, V.J., Loeb, M., Luteijn, J.M., Marshall, H., Nair, H., Pottie, K., Salam, R.A., Savitz, D.A., Serruya, S.J., Skidmore, B., Ortiz, J.R.
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Technical guidance on the Introduction of HPV vaccines in European Union countries – an update
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.